UK Renal Registry, Bristol, UK.
Nephron Clin Pract. 2012;120 Suppl 1:c29-54. doi: 10.1159/000342844. Epub 2012 Sep 1.
This chapter describes the characteristics of adult patients on renal replacement therapy (RRT) in the UK in 2010.
Data were electronically collected from all 72 renal centres within the UK. Cross-sectional and longitudinal analyses were performed to describe the demographics of prevalent RRT patients in 2010 at centre and national level. Age and gender standardised ratios for prevalence rates per million population per year were calculated.
There were 50,965 adult patients receiving RRT in the UK on 31st December 2010. The UK prevalence of RRT (including paediatric patients) was 832 pmp. This represented an annual increase in prevalent numbers of approximately 4% although there was significant variation between centres and regions. From 2009 to 2010 there was a 1.5% increase in the number of patients on haemodialysis (HD), a 3.2% fall in peritoneal dialysis (PD) patients and a 5.4% increase in patients with a functioning transplant. The number of patients receiving home HD has increased 23% since 2009. Median RRT vintage was 5.6 years. The median age was 57.9 years (HD 66.3 years, PD 61.7 years and transplant 51.2 years) compared to 55 years in 2000. Prevalence rates in males exceeded those in females. The most common identifiable renal diagnosis was biopsyproven glomerulonephritis (16.0%), followed by diabetes (14.9%). Transplantation was the most common treatment modality (48%), HD in 44% and PD 8%.
The HD and transplant population continued to expand whilst the PD population contracted. There were national, regional and dialysis centre level variations in prevalence rates. Prevalent patients were on average 4 years older than 10 years ago. This has implications for service planning and ensuring equity of care for RRT patients.
本章描述了 2010 年英国接受肾脏替代治疗（RRT）的成年患者的特点。
数据从英国的 72 个肾脏中心电子收集。在中心和国家层面进行横断面和纵向分析，以描述 2010 年RRT 患者的人口统计学特征。计算了每年每百万人口的患病率的年龄和性别标准化比率。
2010 年 12 月 31 日，英国有 50965 名成年患者接受 RRT。英国 RRT 的患病率（包括儿科患者）为 832 pmp。这代表了流行人数的年增长率约为 4%，尽管中心和地区之间存在显著差异。从 2009 年到 2010 年，血液透析（HD）患者人数增加了 1.5%，腹膜透析（PD）患者人数减少了 3.2%，功能移植患者人数增加了 5.4%。自 2009 年以来，接受家庭 HD 的患者人数增加了 23%。中位 RRT 年龄为 5.6 年。中位年龄为 57.9 岁（HD 为 66.3 岁，PD 为 61.7 岁，移植为 51.2 岁），而 2000 年为 55 岁。男性的患病率高于女性。最常见的可识别肾脏诊断是经活检证实的肾小球肾炎（16.0%），其次是糖尿病（14.9%）。移植是最常见的治疗方式（48%），HD 占 44%，PD 占 8%。
HD 和移植人群继续扩大，而 PD 人群缩小。在患病率方面存在国家、地区和透析中心级别的差异。现患患者的平均年龄比 10 年前大 4 岁。这对服务规划和确保 RRT 患者的护理公平性有影响。
